Moberg Pharma

About Moberg Pharma

Moberg Pharma is a pharmaceutical company focused on developing and commercializing treatments for nail fungus, aiming to make a significant impact on millions of patients worldwide while creating value for shareholders.

Products & Services

MOB-015 (Terclara):An over-the-counter cutaneous solution with terbinafine for treating mild to moderate nail fungus on fingernails and toenails. Market leader in Sweden and Norway, with approval in 13 EU countries.

Specialties

Nail fungus treatment Dermatology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity Funding (Warrant Exercise and Directed Share Issue) T: - FT: Equity Funding (Warrant Exercise and Directed Share Issue)	A: 336000000 MR: - FA: approximately SEK 336 million FAN: 336000000	D: 2024-06-24 FD: 2024-06-24	3 investors
2	RT: Equity Financing via Warrants T: - FT: Equity Financing via Warrants	A: 10669000 MR: - FA: SEK 113.5 million FAN: 10669000	D: 2024-06-11 FD: 2024-06-11	4 investors

Equity Funding (Warrant Exercise and Directed Share Issue) Latest

2024-06-24

$336.0M

3 investors (Pro only)

Equity Financing via Warrants 2024-06-11

$10.7M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jonas Ekblom

Executive Chairman

I

Isabelle Ducellier

O

Otto Skolling

Board Member

N

Nikolaj Sørensen

President and CEO of Orexo AB

R

Richard Ding

Board Member

M

Mona Zhang

Founder and Managing Partner

View 9 more team members with Pro

Unlock Full Team Directory

Recent News

Moberg Pharma Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised